Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Targeting dendritic cells—why bother?

Martin Kreutz, Paul J. Tacken, Carl G. Figdor

Blood (2013) 121 (15): 2836–2844.

https://doi.org/10.1182/blood-2012-09-452078

Published: 2013

Journal Articles

The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3 + myeloid dendritic cells

Gerty Schreibelt, Lieke J. J. Klinkenberg, Luis J. Cruz, Paul J. Tacken, Jurjen Tel, Martin Kreutz, Gosse J. Adema, Gordon D. Brown, Carl G. Figdor, I. Jolanda M. de Vries

Blood (2012) 119 (10): 2284–2292.

https://doi.org/10.1182/blood-2011-08-373944

Published: 2012

Journal Articles

Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity

Paul J. Tacken, Ingrid S. Zeelenberg, Luis J. Cruz, Maaike A. van Hout-Kuijer, Gerline van de Glind, Remco G. Fokkink, Annechien J. A. Lambeck, Carl G. Figdor

Blood (2011) 118 (26): 6836–6844.

https://doi.org/10.1182/blood-2011-07-367615

Published: 2011

Includes: Supplemental data

Journal Articles

Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation

Paul J. Tacken, Wiebke Ginter, Luciana Berod, Luis J. Cruz, Ben Joosten, Tim Sparwasser, Carl G. Figdor, Alessandra Cambi

Blood (2011) 118 (15): 4111–4119.

https://doi.org/10.1182/blood-2011-04-346957

Published: 2011

Includes: Supplemental data

Journal Articles

Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production

Friederike Meyer-Wentrup, Daniel Benitez-Ribas, Paul J. Tacken, Cornelis J. A. Punt, Carl G. Figdor, I. Jolanda M. de Vries, Gosse J. Adema

Blood (2008) 111 (8): 4245–4253.

https://doi.org/10.1182/blood-2007-03-081398

Published: 2008

Includes: Supplemental data

Journal Articles

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody

Paul J. Tacken, I. Jolanda M. de Vries, Karlijn Gijzen, Ben Joosten, Dayang Wu, Russell P. Rother, Susan J. Faas, Cornelis J. A. Punt, Ruurd Torensma, Gosse J. Adema, Carl G. Figdor

Blood (2005) 106 (4): 1278–1285.

https://doi.org/10.1182/blood-2005-01-0318

Published: 2005

Includes: Multimedia, Supplemental data

NARROW

Targeting dendritic cells—why bother?

The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3 + myeloid dendritic cells

Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity

Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation

Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody

Email alerts

ASH Publications

American Society of Hematology

Targeting dendritic cells—why bother?

The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3 + myeloid dendritic cells

Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity

Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation

Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only